关于gsk在寡核苷酸领域的布局 目前，GSK正在推进寡核苷酸用于治疗慢性乙型肝炎和脂肪变性肝病，以及肝病以外的其他治疗领域。 据不完全统计 ...

Drugs giant GSK is set to move its global headquarters back to central London, ending more than two decades at its Brentford base. Around 3,000 employees will work from The Earnshaw building on ...

gsk是一家全球生物制药公司，旨在将科学、技术和人才汇聚起来，共同预防疾病。该公司的目标是在未来10年内通过疫苗、特殊药物和一般药物组合 ...

GSK will be moving on up to a new global headquarters in central London, the British pharma said Monday. The company will move to the new HQ from its current location in Brentford in west London ...

GSK opened the doors to its £300 million Brentford location in 2002 as the biggest single commercial development in the U.K. at the time with four five-story buildings and a 16-story tower block ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

GSK has paid out $100 million cash to Mersana Therapeutics for the potential to add a second antibody-drug conjugate (ADC) to its portfolio, which currently consists of approved multiple myeloma dr ...